Adams Respiratory Lowers Outlook
Adams Respiratory Therapeutics Inc. (ARXT) lowered its outlook for the year sending the stock price plummeting $4.62 to close at $36.10.
posted by FC Market News at 10:29 AM
Tuesday, August 21, 2007
Previous Posts
- Warren Buffet May Purchase Countrywide
- Mortgage Concerns Weighs Down IndyMac
- Kensey Nash Swings To Loss
- Countrywide Begins Layoffs
- KKR To Raise $500 Million
- Thornburg Mortgage Drops
- Lowe's Beats Expectations
- Tetra Technologies Disappoints
- Network Appliance Lowers Outlook
- American Home Mortgage To Suspend Operations
0 Comments:
Post a Comment
<< Home